Fecal Microbiota Transplantation (FMT) & Crohn’s Disease (CD)

There were no eligible randomized controlled trials found for the treatment of Crohn's disease (CD) to support recommendations
Chande et al. 2020 Inflamm Bowel Dis 26: 843-851
Ortigão et al. 2020

No studies have evaluated the effectiveness of Fecal Microbiota Transplantation (FMT) in initiating or sustaining remission in Crohn’s Disease (CD), nor in pediatric participants.
Chande et al. 2020 Inflamm Bowel Dis 26: 843-851

A systematic review of small case series showed an overall efficacy with Fecal Microbiota Transplantation (FMT) of 36%, with Crohn’s patients more likely to respond than those with ulcerative colitis
Colman & Rubin 2014 J Crohns Colitis 8(12): 1569–81

see also:
Fecal Microbiota Transplantation (FMT) & Inflammatory Bowel Disease (IBD)
Fecal Microbiota Transplantation (FMT) (procedure-based) & Preclinical/Clinical data
RBX2660 & Crohn's disease (CD)
RBX7455 & Crohn's disease (CD)